Jorge Gómez‐Miragaya

Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer

Laia Piqué, Alexia Martínez de Paz, David Piñeyro et al. · Oncogene · 2019 · 83 citations · Full text

Rna-binding Protein Celf2, Rna Processing, Medicine +13

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

Jorge Gómez‐Miragaya, Marta Palafox, Laia Paré et al. · Stem Cell Reports · 2017 · 71 citations · Full text

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation

Guillermo Yoldi, Pasquale Pellegrini, Eva M. Trinidad et al. · Cancer Research · 2016 · 65 citations

Receptor Rank, Breast Oncology, Medicine +12

Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs

Adriana Blancafort, Ariadna Giró‐Perafita, Glòria Oliveras et al. · PLoS ONE · 2015 · 60 citations · Full text

Breast Oncology, Anti-her2 Drugs, Endocrine-related Cancer +15

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition

Francesca Mateo, Enrique J. Arenas, H. Aguilar et al. · Oncogene · 2016 · 39 citations · Full text

Tumor Biology, Transcriptional Regulation, Signaling Pathway +17